| http://www.w3.org/ns/prov#value | - This is often displayed as a cost effectiveness acceptability curve.48Heterogeneity in the trial population could also be explored by formulating a net benefit value for each patient from the observed costs and effects, and then constructing a regression model with a treatment variable and covariates such as age, sex, and disease severity.
|
